As of 2025-10-29, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -5.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 253.89 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -49.67 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.0x - 3.2x | 3.1x |
| Forward P/E multiples | 5.6x - 8.1x | 6.8x |
| Fair Price | (3.74) - (2.32) | (3.37) |
| Upside | -221.0% - -175.0% | -209.0% |
| Date | EV/EBITDA |
| 2025-10-27 | -6.01 |
| 2025-10-24 | -5.77 |
| 2025-10-23 | -5.75 |
| 2025-10-22 | -5.96 |
| 2025-10-21 | -6.01 |
| 2025-10-20 | -6.16 |
| 2025-10-17 | -6.48 |
| 2025-10-16 | -7.58 |
| 2025-10-15 | -6.83 |
| 2025-10-14 | -7.05 |
| 2025-10-13 | -7.31 |
| 2025-10-10 | -6.80 |
| 2025-10-09 | -6.82 |
| 2025-10-08 | -7.27 |
| 2025-10-07 | -6.22 |
| 2025-10-06 | -5.78 |
| 2025-10-03 | -5.85 |
| 2025-10-02 | -5.57 |
| 2025-10-01 | -5.41 |
| 2025-09-30 | -4.71 |
| 2025-09-29 | -4.54 |
| 2025-09-26 | -5.76 |
| 2025-09-25 | -5.73 |
| 2025-09-24 | -5.90 |
| 2025-09-23 | -6.07 |
| 2025-09-22 | -6.06 |
| 2025-09-19 | -5.90 |
| 2025-09-18 | -5.40 |
| 2025-09-17 | -5.29 |
| 2025-09-16 | -5.30 |
| 2025-09-15 | -5.23 |
| 2025-09-12 | -5.25 |
| 2025-09-11 | -5.43 |
| 2025-09-10 | -5.09 |
| 2025-09-09 | -4.91 |
| 2025-09-08 | -4.81 |
| 2025-09-05 | -4.58 |
| 2025-09-04 | -4.52 |
| 2025-09-03 | -4.49 |
| 2025-09-02 | -4.45 |
| 2025-09-01 | -4.77 |
| 2025-08-29 | -4.59 |
| 2025-08-28 | -4.60 |
| 2025-08-27 | -4.63 |
| 2025-08-26 | -4.57 |
| 2025-08-25 | -4.76 |
| 2025-08-22 | -4.96 |
| 2025-08-21 | -4.81 |
| 2025-08-20 | -5.03 |
| 2025-08-19 | -5.19 |